Literature DB >> 19027958

Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.

Selina Khan1, Jimmy J Weterings, Cedrik M Britten, Ana R de Jong, Dirk Graafland, Cornelis J M Melief, Sjoerd H van der Burg, Gijs van der Marel, Hermen S Overkleeft, Dmitri V Filippov, Ferry Ossendorp.   

Abstract

Covalent conjugation of synthetic Toll-like receptor ligands (TLR-L) to synthetic antigenic peptides provides well-defined constructs that have significantly improved capacity to induce efficient priming of CD8(+) T lymphocytes in vivo. We have recently explored the cellular mechanisms underlying the efficient induction of a CD8(+) cytotoxic T lymphocyte response by such synthetic model vaccines [Khan, S., Bijker, M.S., Weterings, J.J., Tanke, H.J., Adema, G.J., van, H.T., Drijfhout, J.W., Melief, C.J., Overkleeft, H.S., van der Marel, G.A., Filippov, D.V., van der Burg, S.H., Ossendorp, F., 2007. Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J. Biol. Chem. 282, 21145-21159.]. In the current study we have investigated the behaviour of two diastereomers of the TLR-2 ligand Pam(3)CSK(4) (Pam) derivatives, namely the R- and S-epimers at C-2 of the glycerol moiety. Other studies have shown that the Pam(3)Cys based lipopeptides of R-configuration (Pam(R)) in the glycerol moiety enhanced macrophage and B-cell activation compared to those with S-configuration (Pam(S)). Here we report that Pam(R)-conjugates lead to better activation of dendritic cells than the Pam(S)-conjugates as judged by higher IL-12 secretion, upregulation of relevant markers for dendritic cell maturation. In contrast both epimers were internalized equally efficient in a clathrin-dependent manner indicating no qualitative difference in the uptake of the two stereoisomeric Pam-conjugates. We conclude that the enhanced DC activation is due to enhanced TLR-2 triggering by the Pam(R)-conjugate in contrast to the Pam(S)-conjugate. Importantly, induction of specific CD8(+) T-cells was significantly higher in mice injected with the Pam(R)-conjugates compared to mice injected with the Pam(S)-conjugate. In summary we show that the favourable effects of the Pam(R)-configuration of TLR-2 ligand can be attributed to direct effects on dendritic cells resulting in enhancement of CD8(+) T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027958     DOI: 10.1016/j.molimm.2008.10.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  21 in total

Review 1.  A peptide's perspective on antigen presentation to the immune system.

Authors:  Jacques Neefjes; Huib Ovaa
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

2.  In situ loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunity.

Authors:  Jurjen M Ruben; Hetty J Bontkes; Theresia M Westers; Erik Hooijberg; Gert J Ossenkoppele; Arjan A van de Loosdrecht; Tanja D de Gruijl
Journal:  Oncoimmunology       Date:  2014-07-03       Impact factor: 8.110

3.  Current Prospects in Peptide-Based Subunit Nanovaccines.

Authors:  Prashamsa Koirala; Sahra Bashiri; Istvan Toth; Mariusz Skwarczynski
Journal:  Methods Mol Biol       Date:  2022

4.  Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.

Authors:  Olivier Renaudet; Gargi Dasgupta; Ilham Bettahi; Alda Shi; Anthony B Nesburn; Pascal Dumy; Lbachir BenMohamed
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

5.  The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation.

Authors:  D Tien Nguyen; Lot de Witte; Martin Ludlow; Selma Yüksel; Karl-Heinz Wiesmüller; Teunis B H Geijtenbeek; Albert D M E Osterhaus; Rik L de Swart
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

6.  Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition.

Authors:  Dorian A Stolk; Sophie K Horrevorts; Sjoerd T T Schetters; Laura J W Kruijssen; Sanne Duinkerken; Eelco Keuning; Martino Ambrosini; Hakan Kalay; Rieneke van de Ven; Juan J Garcia-Vallejo; Tanja D de Gruijl; Sandra J van Vliet; Yvette van Kooyk
Journal:  Mol Ther Oncolytics       Date:  2021-04-29       Impact factor: 7.200

Review 7.  Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.

Authors:  Mehfuz Zaman; Istvan Toth
Journal:  Front Immunol       Date:  2013-10-09       Impact factor: 7.561

Review 8.  The Interplay between Daptomycin and the Immune System.

Authors:  Theodoros Kelesidis
Journal:  Front Immunol       Date:  2014-02-12       Impact factor: 8.786

9.  Design, automated synthesis and immunological evaluation of NOD2-ligand-antigen conjugates.

Authors:  Marian M J H P Willems; Gijs G Zom; Nico Meeuwenoord; Ferry A Ossendorp; Herman S Overkleeft; Gijsbert A van der Marel; Jeroen D C Codée; Dmitri V Filippov
Journal:  Beilstein J Org Chem       Date:  2014-06-26       Impact factor: 2.883

Review 10.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.